title: Effects of duloxetine on microRNA expression profile in frontal lobe and hippocampus in a mouse model of depression.
abstract: Depression is a major mood disorder affecting people worldwide. The posttranscriptional gene regulation mediated by microRNAs (miRNAs) which may have critical roles in the pathogenesis of depression. However, to date, little is known about the effects of the antidepressant drug duloxetine on miRNA expression profile in chronic unpredictable mild stress (CUMS)-induced depression model in mice. Healthy adult male Kunming mice were randomly divided into three groups: control group, model group and duloxetine group. Sucrose preference test and open field test were used to represent the behavioral change. MiRNAs levels in frontal lobe and hippocampus of mice were analyzed using miRNA microarrays assay. We observed that long-term treatment with duloxetine significantly ameliorated the CUMS procedure-induced sucrose preference decreases and mice treated with duloxetine demonstrated a reversal of the number of crossings, and rearings reduced by CUMS. A significant upregulation of miR-132 and miR-18a in hippocampus in the duloxetine treatment group compared with model group, whereas the levels of miR-134 and miR-124a were significantly downregulated. Furthermore, miR-18a showed significant upregulation in frontal lobe in the duloxetine treatment group relative to model group. Our data showed that miRNA expression profile in frontal lobe and hippocampus was affected by duloxetine in mice model of depression. The effect was especially pronounced in the hippocampus, suggesting that hippocampus might be the action site of duloxetine, which presumably worked by regulating the expression of miRNA levels.
authors.affiliation: Department of Psychiatry, The Second Affiliated Hospital, Zhejiang University School of Medicine Hangzhou, China.
authors.forename: Bing
authors.initials: B
authors.lastname: Pan
authors.affiliation: National Research Center of Veterinary Biological Engineering and Technology, Jiangsu Academy of Agricultural Sciences Nanjing, Jiangsu, China.
authors.forename: Yamei
authors.initials: Y
authors.lastname: Liu
mesh_terms: D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology*; D001522:Behavior, Animal / Q000187:drug effects; D003863:Depression / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism / Q000503:physiopathology / Q000523:psychology; D004195:Disease Models, Animal; D000068736:Duloxetine Hydrochloride / Q000494:pharmacology*; D005518:Food Preferences / Q000187:drug effects; D005625:Frontal Lobe / Q000187:drug effects* / Q000378:metabolism / Q000503:physiopathology; D020869:Gene Expression Profiling / Q000379:methods; D005786:Gene Expression Regulation / Q000187:drug effects*; D006624:Hippocampus / Q000187:drug effects* / Q000378:metabolism / Q000503:physiopathology; D008297:Male; D051379:Mice; D035683:MicroRNAs / Q000235:genetics* / Q000378:metabolism; D009043:Motor Activity / Q000187:drug effects; D020411:Oligonucleotide Array Sequence Analysis; D013997:Time Factors
chemical_list: D000928:Antidepressive Agents; D035683:MicroRNAs; D000068736:Duloxetine Hydrochloride
keywords: CUMS Duloxetine; depression; frontal lobe; hippocampus; miRNA
references.citation: Clin Psychopharmacol Neurosci. 2014 Apr;12(1):37-40
references.pmid: 24851119
references.citation: BMC Psychiatry. 2005;5:1
references.pmid: 15631624
references.citation: Neuropsychiatr Dis Treat. 2009;5:23-31
references.pmid: 19557096
references.citation: Gene. 2007 Apr 15;391(1-2):39-44
references.pmid: 17229533
references.citation: Genome Biol. 2007;8(8):R173
references.pmid: 17711588
references.citation: Nat Med. 2014 Jul;20(7):764-8
references.pmid: 24908571
references.citation: J Neurosci Res. 2015 Oct;93(10):1476-91
references.pmid: 26010004
references.citation: Acta Psychiatr Scand. 2014 Apr;129(4):241-56
references.pmid: 23952691
references.citation: Eur J Pain. 2014 Jan;18(1):67-75
references.pmid: 23733529
references.citation: Clin Sci (Lond). 2014 Sep;127(6):351-65
references.pmid: 24895056
references.citation: Neuron. 2014 Apr 2;82(1):195-207
references.pmid: 24631344
references.citation: Hippocampus. 2013 Jul;23(7):625-33
references.pmid: 23520022
references.citation: Nature. 2005 Jun 9;435(7043):834-8
references.pmid: 15944708
references.citation: J Cell Biochem. 2010 Jul 1;110(4):834-45
references.pmid: 20564181
references.citation: Exp Clin Endocrinol Diabetes. 2014 Feb;122(2):107-12
references.pmid: 24554510
references.citation: J Psychopharmacol. 2002 Jun;16(2):115-23
references.pmid: 12095069
references.citation: PLoS One. 2011;6(6):e21495
references.pmid: 21731767
references.citation: RNA Biol. 2010 Sep-Oct;7(5):528-33
references.pmid: 20523124
references.citation: Klin Med (Mosk). 1974 Apr;52(4):70-3
references.pmid: 4459569
references.citation: Med Sci Monit. 2014;20:499-512
references.pmid: 24675061
references.citation: Life Sci. 2014 Mar 7;98(1):18-23
references.pmid: 24394957
references.citation: Neurosci Res. 2012 Jul;73(3):179-90
references.pmid: 22521503
references.citation: Cell. 2004 Jan 23;116(2):281-97
references.pmid: 14744438
references.citation: Med Sci Monit. 2013;19:1146-58
references.pmid: 24335907
references.citation: BMC Psychiatry. 2014;14:74
references.pmid: 24625135
references.citation: J Psychiatry Neurosci. 2014 Sep;39(5):348-59
references.pmid: 25079084
references.citation: Cancer Lett. 2014 May 28;347(1):29-37
references.pmid: 24513178
references.citation: Exp Cell Res. 2014 Feb 1;321(1):84-9
references.pmid: 24099990
references.citation: Nature. 2010 Aug 26;466(7310):1105-9
references.pmid: 20622856
references.citation: Rehabil Psychol. 2015 Feb;60(1):81-90
references.pmid: 25602361
references.citation: Biol Psychiatry. 2008 Feb 15;63(4):385-90
references.pmid: 17640621